Acasta Enterprises Completes Sale of JemPak and Reduction of its Indebtedness

Jun 01, 2018 08:41 am

Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the “Company”) announced today that it has completed the previously announced sale (the “Transaction”) of JemPak Corporation to a wholly-owned subsidiary of Henkel AG & Co. KGaA.

“With the closing of this Transaction, Acasta has been able to significantly reduce its indebtedness and reduce the associated cost of borrowing on its remaining indebtedness,” commented Ian Kidson, Interim Chief Executive of the Company. “We would like to thank our lenders for their constructive dialogue with us and assistance in implementing the closing of the Transaction.”

The net proceeds from the Transaction of approximately $115 million were used primarily to pay down Acasta’s indebtedness. Acasta has repaid approximately $77.3 million (U.S.$59 million) under its U.S.$150 million credit facility leaving only approximately U.S.$10 million in indebtedness to WFI Inc., an entity controlled by Charles and Richard Wachsberg.

In addition, Acasta has entered into an amending agreement with Canadian Imperial Bank of Commerce whereby it remains as the only lender to Apollo Health and Beauty Care Inc. (“Apollo”) in the amount of approximately $58 million which is secured by a first ranking charge over all property of Apollo as well as a pledge of all equity interests and indebtedness of Apollo held by Acasta. As of the date hereof, the Company’s aggregate indebtedness is approximately $74 million.

Canaccord Genuity Corp. served as financial advisor and Goodmans LLP acted as legal counsel to Acasta, respectively.

Acasta Enterprises Inc.
Ian Kidson, 1-647-725-6707
Interim Chief Executive Officer